Evaluation of kidney and liver subacute toxicity induced by Bezalip - Pravastatin - Lopid antihyperlipidaemic compounds in rats

Biochemistry and Molecular Biology International

Volumn 47, Issue 3, 1999, Pages 519-528

  Pispirigos, K ^a   Simopoulos, K ^a   Kouskoukis, K ^a   Kounis, N ^a   Avramopoulos, A ^a  

^a NONE

Author keywords

Antihyperlipidaemic drugs; Bezalip; In vivo studies; Lopid; Pravastatin; Subacute toxicity; glutamyltransferase enzyme

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTILIPEMIC AGENT; ASPARTATE AMINOTRANSFERASE; BEZAFIBRATE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GEMFIBROZIL; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; POTASSIUM; PRAVASTATIN; SODIUM; UREA; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LIVER; MALE; MEDICAL INSTRUMENTATION; NONHUMAN; POTASSIUM BLOOD LEVEL; RAT; SODIUM BLOOD LEVEL; TOXICITY; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 0032916301     PISSN: 10399712     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216549900201553     Document Type: Article

References (20)

1. Loeb, W.F., and Quimby, F.W. (1989) in The Clinical Chemistry of Laboratory Animals, Pergamon Press Inc., New York.
2. Pispirigos, K., Catsoulakos, P., Karakiulakis, G. (1993) Biochem. Mol. Biol. Int. 31, 565-573.
3. th ed. Little, Brown and Co., Boston.
4. nd ed. Mosby-Year Book, Inc., St. Louis.
5. McIntyre, N. and Harry, D.S. (1991) in Lipids and Lipoproteins in Clinical Practice, Wolfe Publ. Ltd., London.
6. rd ed. Mosby-Year Book Inc., St. Louis.
7. Weinberg, A.R. (1984) in Scientific American Medicine, (E. Rubenstein, and D.D. Federman Eds.), vol. 2, Chapter 12. Scientific American Incorp., New York.
8. Kodak Clinical Products, (1988) in Test Methodologies for in vitro Diagnostic Use. Kodak Ektachem DT System. (Eastman Kodak Company, Ed.), Rochester, New York.
9. Pispirigos, K., Paradelis, A., Karakiulakis, G. (1997) Arzneim-Forsch / Drug Res. 47(1), 1, 92-96.
10. Bergmeyer, H.U., Scheibe, P., and Wahlefeld, A.W. (1978) Clin. Chem. 24, 58-73.
11. Szasz, G. (1969) Clin. Chem. 15, 124-136.
12. Harrisson, S.D. Jr., Burdeshaw, J.A., Crosby, R.G., Cusic, A.M., and Denine, E.P. (1978) Cancer Res. 38, 2636.
13. th ed, pp. 1202-1263. Pergamon Press, New York.
14. Lameire, N.H., Lifschitz, M.D., and Stin, J.H. (1997) Annu. Rev. Physiol. 39, 159-184.
15. Boyd, J.W. (1983) Vet. Clin. Pathol. 12, 9-24.
16. Mitruka, B.M., and Rawnsley, H.M. (1977) in Clinical, Biochemical and Hematological Reference Values in Normal Experimental Animals. Masson, New York.
17. Meeks, R.G. (1989) in The Clinical Chemistry of Laboratory Animals (W.F. Loeb and F.W. Quimby, Eds). Pergamon Press Inc., New York.
18. Wootton, A.M., Neale, G., and Moss, D.W. (1977) Clin. Sci. Mol. Med. 52, 585-590.
19. Stegmeir, K., Stork, H., Lenz, H., et. al. (1980) Pharmacology and mode action of bezafibrate in animals. In: Greten, H., Lang, P.D., and Schettler, G.; eds -, Lipoproteins and coronary heart disease, New York: Witzstrock Publsihing House, 76:.
20. Pan H. Y. (1989) Pharmacokinetics, Pharmacodynamics and Safety of Pravastatin Sodium, a Patent Inhibitor of HMG-CoA Reductase, in Healthy Volunteers. In New Advances in the Control of Lipid Metabolism: Focus on Pravastatin, Royal Soc. Med. Serv. Eds. 9-21.